Risk factors, thromboembolic events, and clinical course of New-Onset Atrial Fibrillation among COVID-19 hospitalized patients: A multicenter cross-sectional analysis in Iran.
Fatemeh Sadat RahimiSiamak AfaghiFarzad Esmaeili TarkiHossein Salehi OmranMohammad Hossein NasirpourPublished in: Health science reports (2022)
In hospitalized COVID-19 patients with NOAF, the risk of thromboembolic events, hospital stay, and fatality are significantly higher. The established risk factors showed that patients with older age, higher inflammation states, and more severe clinical conditions based on CHADS2VASC-score potentially need subsequent preventive strategies. Appropriate prophylactic anticoagulants, Initial management of cytokine storm, sufficient oxygen support, and reducing viral shedding could be of assistance in such patients.
Keyphrases
- atrial fibrillation
- risk factors
- sars cov
- cross sectional
- end stage renal disease
- coronavirus disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- oxidative stress
- healthcare
- left atrial
- prognostic factors
- heart failure
- left atrial appendage
- peritoneal dialysis
- physical activity
- direct oral anticoagulants
- clinical trial
- respiratory syndrome coronavirus
- percutaneous coronary intervention
- patient reported outcomes
- double blind
- drug induced
- adverse drug